Buscar resultados de ensayos clínicos

Patrocinado por

Nephrotic Syndrome - 5 Studies Found

Estado Estudiar
Completed Nombre del estudio: Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
Condición: Nephrotic Syndrome
Fecha: 2016-12-16
Intervenciones:
  • Drug: Alirocumab 150 mg biweek
NOT_YET_RECRUITING Nombre del estudio: Effectiveness of Educational Gamified Cards About Nephrotic Syndrome
Condición:
Fecha: 2025-11-04
Intervenciones:
  • The study intervention "Spin to Win - Nephro Cards" will include the following items with simple Arabic language and graphic designa
NOT_YET_RECRUITING Nombre del estudio: Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condición: Nephrotic Syndrome
Fecha: 2025-11-04
Intervenciones: ADX-629 (250 milligrams) administered twice daily
Completed Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
Condición: Childhood Idiopathic Nephrotic Syndrome
Fecha: 2025-11-04
Intervenciones: Obinutuzumab will be administered as per schedule specified in the respective arm.
COMPLETED Nombre del estudio: B Cells in Idiopathic Nephrotic Syndrome
Condición: Nephrotic Syndrome
Fecha: 2025-11-04
Intervenciones: Before the anti-CD20 monoclonal antibodies treatment (e.g.Rituximab/Ofatumumab) and after 6, 9 and 12, 24 months from the first infusion